Expert Opinion on Therapeutic Targets This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Lipid-laden foam cells in the pathology of atherosclerosis: shedding light on new therapeutic targets
Volume 27, Issue 12, July - December 2023, Page 1231-1245 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 30, 2023 Category: Drugs & Pharmacology Authors: Cristi L. GalindoSaifur KhanXiangyu ZhangYu-Sheng YehZiyang LiuBabak Razania Vascular Medicine Institute, Department of Medicine, University of Pittsburgh School of Medicine and UPMC, Pittsburgh, PA, United Statesb Department of Cardiology, Pittsburgh VA Source Type: research

Decoding the expression pattern of MUC3A in gastric adenocarcinoma: unveiling the key to successful immunotherapy
Volume 27, Issue 12, July - December 2023, Page 1299-1305 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 30, 2023 Category: Drugs & Pharmacology Authors: Masoud SotoudehVahid MansouriRamin ShakeriBahareh SharififardNasim SajadiVahid HaghpanahMahmood Naderia Digestive Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iranb Digestive Oncology Rese Source Type: research

miR-26a-5p restoration via EZH2 silencing blocks the IL-6/STAT3 axis to repress the growth of prostate cancer
Volume 27, Issue 12, July - December 2023, Page 1285-1297 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 30, 2023 Category: Drugs & Pharmacology Authors: Wenqiang ZhangQiwei NieXuling ZhangLong HuangGuofu PangJing ChuXiaoxu Yuana Department of Urology, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, Chinab Department of Urology, Zhuhai Peo Source Type: research

Powering down the mitochondrial LonP1 protease: a novel strategy for anticancer therapeutics
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 29, 2023 Category: Drugs & Pharmacology Authors: Rahul ShettyRoberto NolandGhata NandiCarolyn K. SuzukiDepartment of Microbiology, Biochemistry & Molecular Genetics, Rutgers University- New Jersey Medical School, Newark, NJ, USA Source Type: research

miR-26a-5p restoration via EZH2 silencing blocks the IL-6/STAT3 axis to repress the growth of prostate cancer
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 29, 2023 Category: Drugs & Pharmacology Authors: Wenqiang ZhangQiwei NieXuling ZhangLong HuangGuofu PangJing ChuXiaoxu Yuana Department of Urology, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, Chinab Department of Urology, Zhuhai Peo Source Type: research

Targeting GABA receptors with chalcone derivative compounds, what is the evidence?
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 19, 2023 Category: Drugs & Pharmacology Authors: Feba BennySunil KumarAiswarya BinuDella Grace Thomas ParambiTariq G. AlsahliAbdullah G. Al-SehemiNamitha ChandranDeepthi S. ManishaSarath SreekumarAkanksha BhattKrishnadas MadhuBijo Mathewa Department of Pharmaceutical Chemistry, Amrita School of Pharmacy Source Type: research

Novel signatures of prostate cancer progression and therapeutic resistance
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 18, 2023 Category: Drugs & Pharmacology Authors: Jason WangReuben Ben-DavidReza MehrazinWei YangAshutosh K. TewariNatasha Kyprianoua Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USAb The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USAc Source Type: research

How will the identification and therapeutic intervention of genetic targets in oncology evolve for future therapy?
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 14, 2023 Category: Drugs & Pharmacology Authors: Paolo BaldoValli De ReMattia Garuttia Hospital Pharmacy Unit, Centro di Riferimento Oncologico di Aviano, CRO Aviano, National Cancer Institute, IRCCS, Aviano, Italyb Immunopathology and Cancer Biomarkers Unit, Centro di Riferimento Oncologico di Aviano, Source Type: research

XBP1 as a novel molecular target to attenuate drug resistance in hepatocellular carcinoma
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 11, 2023 Category: Drugs & Pharmacology Authors: Zahra HendiPedram Asadi SarabiDavid HayMassoud Vosougha Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Academic Center for Education, Culture and Research (ACECR), Tehran, Iranb Dep Source Type: research

Advances in targeting the extracellular matrix for glaucoma therapy: current updates
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 9, 2023 Category: Drugs & Pharmacology Authors: Renu AgarwalIgor IezhitsaSchool of Medicine, International Medical University, Kuala Lumpur, Malaysia Source Type: research

Decoding the expression pattern of MUC3A in gastric adenocarcinoma: unveiling the key to successful immunotherapy
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 9, 2023 Category: Drugs & Pharmacology Authors: Masoud SotoudehVahid MansouriRamin ShakeriBahareh SharififardNasim SajadiVahid HaghpanahMahmood Naderia Digestive Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iranb Digestive Oncology Rese Source Type: research

Unraveling therapeutic targets in acute myeloid leukemia through multiplexed genome editing CRISPR screening
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 9, 2023 Category: Drugs & Pharmacology Authors: Zhen TianStacia OctavianiJian Huanga Coriell Institute for Medical Research, Camden, NJ, USAb Center for Metabolic Disease Research, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USAc Cooper Medical School of Rowan University, Camden, Source Type: research

Leveraging AI to identify dual-purpose aging and disease targets
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 1, 2023 Category: Drugs & Pharmacology Authors: Geoffrey Ho Duen LeungChun Wai WongFrank W. PunAlex AliperFeng RenAlex Zhavoronkova Insilico Medicine Hong Kong Ltd, Hong Kong Science and Technology Park, Hong Kong, Chinab Insilico Medicine AI Ltd, Abu Dhabi, United Arab Emiratesc Insilico Medicine Shan Source Type: research